The Glycolytic Switch in Tumors: How Many Players Are Involved?

Reprogramming of cellular metabolism is a hallmark of cancers. Cancer cells more readily use glycolysis, an inefficient metabolic pathway for energy metabolism, even when sufficient oxygen is available. This reliance on aerobic glycolysis is called the Warburg effect, and promotes tumorigenesis and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Cancer 2017-01, Vol.8 (17), p.3430-3440
Main Authors: Yu, Li, Chen, Xun, Sun, Xueqi, Wang, Liantang, Chen, Shangwu
Format: Article
Language:English
Subjects:
Review
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c441t-350c272670de68f7e31bbf02cff5a7f916e9739d72221a674a626d7724e31f5d3
cites
container_end_page 3440
container_issue 17
container_start_page 3430
container_title Journal of Cancer
container_volume 8
creator Yu, Li
Chen, Xun
Sun, Xueqi
Wang, Liantang
Chen, Shangwu
description Reprogramming of cellular metabolism is a hallmark of cancers. Cancer cells more readily use glycolysis, an inefficient metabolic pathway for energy metabolism, even when sufficient oxygen is available. This reliance on aerobic glycolysis is called the Warburg effect, and promotes tumorigenesis and malignancy progression. The mechanisms of the glycolytic shift in tumors are not fully understood. Growing evidence demonstrates that many signal molecules, including oncogenes and tumor suppressors, are involved in the process, but how oncogenic signals attenuate mitochondrial function and promote the switch to glycolysis remains unclear. Here, we summarize the current information on several main mediators and discuss their possible mechanisms for triggering the Warburg effect.
doi_str_mv 10.7150/jca.21125
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5687156</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1966444367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-350c272670de68f7e31bbf02cff5a7f916e9739d72221a674a626d7724e31f5d3</originalsourceid><addsrcrecordid>eNpVkE1PAjEQhhujEYIc_AOmRz2A249tWQ8SQhRMMJqI56Z0W1nS3WK7C9l_7yJIcC4zyTx5Z_IAcI2iPkdxdL9Sso8RwvEZaKMB4b2EMXp-MrdAN4RV1BRJMKfkErRwgmKUYNYGw_lSw4mtlbN1mSn4sc1KtYRZAedV7nx4gFO3ha-yqOG7lbX2AY68hi_FxtmNTodX4MJIG3T30Dvg8_lpPp72Zm-Tl_Fo1lOUorJH4khhjhmPUs0GhmuCFgsTYWVMLLlJENMJJ0nKMcZIMk4lwyzlHNOGNHFKOuBxn7uuFrlOlS5KL61Y-yyXvhZOZuL_psiW4sttRMwGjSbWBNweArz7rnQoRZ4Fpa2VhXZVEGinilLCeIPe7VHlXQhem-MZFImdc9E4F7_OG_bm9K8j-WeY_ABv5HuA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1966444367</pqid></control><display><type>article</type><title>The Glycolytic Switch in Tumors: How Many Players Are Involved?</title><source>PubMed</source><creator>Yu, Li ; Chen, Xun ; Sun, Xueqi ; Wang, Liantang ; Chen, Shangwu</creator><creatorcontrib>Yu, Li ; Chen, Xun ; Sun, Xueqi ; Wang, Liantang ; Chen, Shangwu</creatorcontrib><description>Reprogramming of cellular metabolism is a hallmark of cancers. Cancer cells more readily use glycolysis, an inefficient metabolic pathway for energy metabolism, even when sufficient oxygen is available. This reliance on aerobic glycolysis is called the Warburg effect, and promotes tumorigenesis and malignancy progression. The mechanisms of the glycolytic shift in tumors are not fully understood. Growing evidence demonstrates that many signal molecules, including oncogenes and tumor suppressors, are involved in the process, but how oncogenic signals attenuate mitochondrial function and promote the switch to glycolysis remains unclear. Here, we summarize the current information on several main mediators and discuss their possible mechanisms for triggering the Warburg effect.</description><identifier>ISSN: 1837-9664</identifier><identifier>EISSN: 1837-9664</identifier><identifier>DOI: 10.7150/jca.21125</identifier><identifier>PMID: 29151926</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Review</subject><ispartof>Journal of Cancer, 2017-01, Vol.8 (17), p.3430-3440</ispartof><rights>Ivyspring International Publisher 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-350c272670de68f7e31bbf02cff5a7f916e9739d72221a674a626d7724e31f5d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687156/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687156/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,730,783,787,888,27936,27937,53804,53806</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29151926$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Li</creatorcontrib><creatorcontrib>Chen, Xun</creatorcontrib><creatorcontrib>Sun, Xueqi</creatorcontrib><creatorcontrib>Wang, Liantang</creatorcontrib><creatorcontrib>Chen, Shangwu</creatorcontrib><title>The Glycolytic Switch in Tumors: How Many Players Are Involved?</title><title>Journal of Cancer</title><addtitle>J Cancer</addtitle><description>Reprogramming of cellular metabolism is a hallmark of cancers. Cancer cells more readily use glycolysis, an inefficient metabolic pathway for energy metabolism, even when sufficient oxygen is available. This reliance on aerobic glycolysis is called the Warburg effect, and promotes tumorigenesis and malignancy progression. The mechanisms of the glycolytic shift in tumors are not fully understood. Growing evidence demonstrates that many signal molecules, including oncogenes and tumor suppressors, are involved in the process, but how oncogenic signals attenuate mitochondrial function and promote the switch to glycolysis remains unclear. Here, we summarize the current information on several main mediators and discuss their possible mechanisms for triggering the Warburg effect.</description><subject>Review</subject><issn>1837-9664</issn><issn>1837-9664</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PAjEQhhujEYIc_AOmRz2A249tWQ8SQhRMMJqI56Z0W1nS3WK7C9l_7yJIcC4zyTx5Z_IAcI2iPkdxdL9Sso8RwvEZaKMB4b2EMXp-MrdAN4RV1BRJMKfkErRwgmKUYNYGw_lSw4mtlbN1mSn4sc1KtYRZAedV7nx4gFO3ha-yqOG7lbX2AY68hi_FxtmNTodX4MJIG3T30Dvg8_lpPp72Zm-Tl_Fo1lOUorJH4khhjhmPUs0GhmuCFgsTYWVMLLlJENMJJ0nKMcZIMk4lwyzlHNOGNHFKOuBxn7uuFrlOlS5KL61Y-yyXvhZOZuL_psiW4sttRMwGjSbWBNweArz7rnQoRZ4Fpa2VhXZVEGinilLCeIPe7VHlXQhem-MZFImdc9E4F7_OG_bm9K8j-WeY_ABv5HuA</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Yu, Li</creator><creator>Chen, Xun</creator><creator>Sun, Xueqi</creator><creator>Wang, Liantang</creator><creator>Chen, Shangwu</creator><general>Ivyspring International Publisher</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>The Glycolytic Switch in Tumors: How Many Players Are Involved?</title><author>Yu, Li ; Chen, Xun ; Sun, Xueqi ; Wang, Liantang ; Chen, Shangwu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-350c272670de68f7e31bbf02cff5a7f916e9739d72221a674a626d7724e31f5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Li</creatorcontrib><creatorcontrib>Chen, Xun</creatorcontrib><creatorcontrib>Sun, Xueqi</creatorcontrib><creatorcontrib>Wang, Liantang</creatorcontrib><creatorcontrib>Chen, Shangwu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Li</au><au>Chen, Xun</au><au>Sun, Xueqi</au><au>Wang, Liantang</au><au>Chen, Shangwu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Glycolytic Switch in Tumors: How Many Players Are Involved?</atitle><jtitle>Journal of Cancer</jtitle><addtitle>J Cancer</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>8</volume><issue>17</issue><spage>3430</spage><epage>3440</epage><pages>3430-3440</pages><issn>1837-9664</issn><eissn>1837-9664</eissn><abstract>Reprogramming of cellular metabolism is a hallmark of cancers. Cancer cells more readily use glycolysis, an inefficient metabolic pathway for energy metabolism, even when sufficient oxygen is available. This reliance on aerobic glycolysis is called the Warburg effect, and promotes tumorigenesis and malignancy progression. The mechanisms of the glycolytic shift in tumors are not fully understood. Growing evidence demonstrates that many signal molecules, including oncogenes and tumor suppressors, are involved in the process, but how oncogenic signals attenuate mitochondrial function and promote the switch to glycolysis remains unclear. Here, we summarize the current information on several main mediators and discuss their possible mechanisms for triggering the Warburg effect.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>29151926</pmid><doi>10.7150/jca.21125</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1837-9664
ispartof Journal of Cancer, 2017-01, Vol.8 (17), p.3430-3440
issn 1837-9664
1837-9664
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5687156
source PubMed
subjects Review
title The Glycolytic Switch in Tumors: How Many Players Are Involved?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-13T09%3A41%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Glycolytic%20Switch%20in%20Tumors:%20How%20Many%20Players%20Are%20Involved?&rft.jtitle=Journal%20of%20Cancer&rft.au=Yu,%20Li&rft.date=2017-01-01&rft.volume=8&rft.issue=17&rft.spage=3430&rft.epage=3440&rft.pages=3430-3440&rft.issn=1837-9664&rft.eissn=1837-9664&rft_id=info:doi/10.7150/jca.21125&rft_dat=%3Cproquest_pubme%3E1966444367%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-350c272670de68f7e31bbf02cff5a7f916e9739d72221a674a626d7724e31f5d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1966444367&rft_id=info:pmid/29151926&rfr_iscdi=true